Development of a General Composite Scale (GENCOMS) for Progressive Neurodegenerative Diseases and Implications for the Assessment of Disease-Modifying Therapies
Abstract Introduction The reliable assessment of treatment outcomes for disease-modifying therapies (DMT) in neurodegenerative disease is challenging. The objective of this paper is to describe a generalized framework for developing composite scales that can be applied in diverse, degenerative condi...
Saved in:
| Main Authors: | Samuel P. Dickson, Craig H. Mallinckrodt, Basia Rogula, Lauren C. Powell, Michele H. Potashman, Vladimir Coric, Gilbert J. L’Italien, Suzanne B. Hendrix |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-09-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-024-00661-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of PARCOMS Composite Scales for Assessing Disease Progression and Treatment Effects in Parkinson’s Disease
by: Gil L’Italien, et al.
Published: (2025-06-01) -
Melatonin—A Powerful Antioxidant in Neurodegenerative Diseases
by: Renata Kołodziejska, et al.
Published: (2025-07-01) -
Inflammasomes in neurodegenerative diseases
by: Qianchen Wang, et al.
Published: (2024-12-01) -
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
by: Yinghui Li, et al.
Published: (2024-12-01) -
Editorial: Neuroinflammation and neurodegenerative diseases
by: Pradeep Kumar, et al.
Published: (2025-02-01)